Innospec

Innospec is a global specialty chemicals company focused on bringing innovative new technologies to market combined with a fast and responsive service. We serve a range of industries across the world, bringing our products to customers in markets from oilfields, fuels, refineries and power stations to personal care. Our global team of approximately 1300 employees spans 20 countries, applying their extensive experience and market understanding to customers’ local needs. Integrating our global footprint with local service capability enables us to supply quality products that meet and anticipate changing market dynamics.
Type
Public
HQ
Englewood, US
Founded
1938
Size (employees)
1,800 (est)+39%
Innospec was founded in 1938 and is headquartered in Englewood, US

Innospec Office Locations

Innospec has an office in Englewood
Englewood, US (HQ)
350 8310 S Valley Hwy

Innospec Metrics

Innospec Financial Metrics

Revenue (2016)

$883.4 m

Revenue growth (2015-16), %

(13%)

Gross profit

$1.4 b

Gross profit margin (2016), %

162%

Net income (2016)

$81.3 m

Market capitalization (21-Mar-2017)

$1.5 b

Closing share price (21-Mar-2017)

$62.6

Cash (31-Dec-2016)

$101.9 m
Innospec's current market capitalization is $1.5 b.
Innospec's revenue was reported to be $883.4 m in FY, 2016 which is a 12.7% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$818.8 m$960.9 m$1 b$883.4 m

Revenue growth, %

17%5%(13%)

Cost of goods sold

$563.6 m$658.9 m($666.3 m)($551.1 m)

Gross profit

$255.2 m$302 m$1.7 b$1.4 b

Gross profit Margin, %

31%31%166%162%

R&D expense

$21.2 m$22.2 m

General and administrative expense

$142.1 m$169.2 m

Operating expense total

$164.6 m$189.5 m$189.7 m($226.9 m)

EBIT

$90.6 m$112.5 m$156.3 m$105.4 m

EBIT margin, %

11%12%15%12%

Interest expense

$2.3 m$3.8 m($4 m)($3.2 m)

Interest income

$400 k$400 k($4 m)($3.2 m)

Pre tax profit

$92.8 m$110.9 m$152.3 m$103.1 m

Income tax expense

$15 m$26.8 m($32.8 m)($21.8 m)

Net Income

$77.8 m$84.1 m$119.5 m$81.3 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$80.2 m$41.6 m$136.9 m$101.9 m

Accounts Receivable

Inventories

Current Assets

$407.4 m$414.2 m$458.7 m$441.1 m

Goodwill

$187.9 m$276.1 m$267.4 m$374.8 m

Total Assets

$794.7 m$999.9 m$1 b$1.2 b

Accounts Payable

$63.3 m$87.6 m$52.2 m$59.6 m

Total Debt

$148 m$139.4 m$268.8 m

Current Liabilities

$155.6 m$222.9 m$206.1 m$183.1 m

Additional Paid-in Capital

$308.8 m$308.8 m$311 m$315.1 m

Retained Earnings

$327.5 m$391.8 m$496.4 m$561.8 m

Total Equity

$409.4 m$515.9 m$605.3 m$653.8 m

Debt to Equity Ratio

0.4 x0.3 x0.4 x

Debt to Assets Ratio

0.2 x0.1 x0.2 x

Financial Leverage

1.9 x1.9 x1.7 x1.8 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$77.8 m$84.1 m$119.5 m$81.3 m

Depreciation and Amortization

$20.4 m$29.1 m$35.2 m$38.1 m

Accounts Receivable

Inventories

($10 m)($11 m)$5.5 m$7.7 m

Accounts Payable

Cash From Operating Activities

$57.8 m($38.6 m)$117.7 m$104.5 m

Capital Expenditures

($11.1 m)($13.5 m)($17.6 m)($16.5 m)

Cash From Investing Activities

($116.1 m)($119 m)$15 m($209.1 m)

Free Cash Flow

$135.3 m$121 m

Innospec Market Value History

Innospec Online Presence

Innospec Company Life

You may also be interested in